SCM
RMD icon

Semanteon Capital Management’s ResMed RMD Stock Holding History

Semanteon Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+1,161
New +$241K 1.02% 61
2025
Q4 		– Sell
-2,048
Closed -$561K – 141
2025
Q3 		$561K Buy
+2,048
New +$559K 0.7% 83
2025
Q1 		– Sell
-5,140
Closed -$1.18M – 341
2024
Q4 		$1.18M Buy
5,140
+243
+5% +$58.5K 0.63% 66
2024
Q3 		$1.2M Buy
4,897
+2,854
+140% +$638K 0.81% 18
2024
Q2 		$391K Buy
+2,043
New +$415K 0.28% 135

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Semanteon Capital Management's RMD Position: Q2 2026 in Review

Semanteon Capital Management opened a new position in ResMed (RMD) in Q2 2026: 1,161 shares worth $226K. The stake represents 1.02% of the portfolio and ranks #61 among its holdings. This is a return to the name: Semanteon Capital Management previously reported a position in RMD as recently as Q3 2025.

Semanteon Capital Management first reported a position in RMD in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.2M in Q3 2024. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Semanteon Capital Management held 1,161 shares of ResMed worth $226K as of Q2 2026.
  • ResMed was a new Semanteon Capital Management position in Q2 2026.
  • ResMed made up 1.02% of Semanteon Capital Management's portfolio in Q2 2026, its #61 holding.
  • Semanteon Capital Management first reported a position in ResMed in Q2 2024 and has held it in 5 quarters since.
  • Semanteon Capital Management's ResMed position peaked at $1.2M in Q3 2024.
  • 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Semanteon Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.